key: cord-0817744-w375nabi
authors: O'Sullivan, Nancy L.; Montgomery, Paul C.; Sullivan, David A.
title: Ocular Mucosal Immunity
date: 2007-05-09
journal: Mucosal Immunology
DOI: 10.1016/b978-012491543-5/50090-5
sha: fd3a384f4c327dd4eed0214e1205adb3f75fedce
doc_id: 817744
cord_uid: w375nabi

nan

Transport of J-linked dimeric IgA from plasma cell to interstitium 2.

IgA transport to acinar epithelium 3.

Secretory component ( ) is added 4.

Dimeric secretory IgA (S-IgA) secretion 5.

S-IgA in lacrimal secretion Schematic representation of the secretory immune system of the human lacrimal gland. Topographical features include acinar cells, which contain endoplasmic reticulum (ER) and lysozyme-and lactoferrin-positive zymogen granules (ZG), and synthesize and secrete secretory component (SC); myoepithelial cells, which are adjacent to acinar cells and surrounded by a basement membrane (BM); interstitial plasma cells, which are the primary lymphoid cell and produce principally IgA, but also some IgG, IgM or IgD; T helper (T H ) and suppressor (T S ) cells, which are distributed throughout the interstitium, the intercellular spaces between acinar or ductal cells, and the periductular lymphoid aggregates; B cells (B), OKT6 + Langerhans-type dendritic cells (DC), and OKM1 + monocyte-macrophages are predominantly located in periductular lymphoid aggregates, which most often appear as primary follicles without germinal center formation and may be active in antigen processing; and unlabelled, darkened cells, which refer to circulating T or B lymphocytes, which may originate in other mucosal tissues (e.g., intestinal Peyer's patch) and, if not retained locally, possibly exit the lacrimal gland through lymphatic channels to regional cervical or preauricular lymph nodes. Immunoglobulin A is secreted by plasma cells, bound by SC on the acinar cell basolateral membrane, transported in distinct vesicles, and released at the apical surface as S-IgA into tear-containing lumina. (This figure has been reproduced and published courtesy of Ophthalmology 1988; 95: 100-109.) stitial regions, and within small, periductular, lymphoid aggregates. The distribution of T cells varies topographically by subclass, which include CD8 + suppressor/cytotoxic and CD4 + helper T cells, which have a helper:suppressor ratio of approximately 0.5. Minor populations of lacrimal immunocytes include surface Ig-bearing B cells, Langerhans-type dendritic cells, monocyte-macrophages, and activated, IL-2positive T cells, which occur almost exclusively in periductular foci, appearing as primary follicles without germinal centers (Wieczorek et al., 1988; Dua et al., 1994; Pepose et al., 1996) . Lacrimal glands of rats, rabbits, and mice share the immune features of the human gland (see Table 86 .1).

In addition to S-IgA, the lacrimal gland supplies a number of nonspecific factors to the aqueous layer of the tear film that contribute to the mucosal defense of the outer eye. Lacrimal acinar cells produce lysozyme, lactoferrin, and βlysin, which have antibacterial properties. Lysozyme is a bacteriolytic enzyme that makes up 40% of tear protein Gillette et al., 1981) . Although its existence in tears has been debated (Janssen et al., 1984) , the nonlysozyme factor β-lysin is also bacteriolytic (Ford et al., 1976) . Lactoferrin makes up 25% of the protein in human tears and has several functions. It enhances the function of NK cells, it deprives bacteria of iron, and it inhibits the formation of biologically active complement by inhibiting the formation of C3 convertase (Arnold et al., 1982; Kijlstra et al., 1983; Kievits and Kijlstra, 1985; Mestecky and McGhee, 1987; Caccavo et al., 2002) . Lacrimal glands also produce and secrete into the tears antimicrobial peptides including defensins (Haynes et al., 1998) . Many additional molecules including growth factors and cytokines related to ocular surface health are produced in the lacrimal gland and have been identified in tears. The immunologic characteristics of human accessory lacrimal tissue appear to be identical to those of the major lacrimal gland (Gillette et al., , 1981 Sacks et al., 1986) .

The migration of lymphocytes into the lacrimal gland appears to be random (McGee and Franklin, 1984 ).Yet, the selective retention and heterogenous distribution of IgAcontaining or T cells within lacrimal tissue are not random and may be stimulated by antigenic challenge and regulated by microenvironmental, endocrine, neural, T-cell, and/or acinar epithelial cell signals (Jackson and Mestecky, 1981; Franklin et al., 1985; Walcott et al., 1986; Allansmith et al., 1987; Hann et al., 1988; Franklin et al., 1988; Franklin, 1989; Franklin and Shephard, 1990; Sullivan et al., 1990a Sullivan et al., , 1998 . The lymphocytic accumulation in, or adherence to, lacrimal tissue appears to require receptors, divalent cations, intact metabolic, oxidative phosphorylation, and contractile microfilament systems, and to depend upon cellular surface protein and carbohydrate determinants (O' Sullivan and Montgomery, 1990; O'Sullivan et al., 1994a O'Sullivan et al., , 1994b O'Sullivan et al., , 1995 .

The conjunctival tissue consists of an outer squamous epithelial cell layer (two to five cells thick) interspersed with goblet cells, a basement membrane, and underlying stromal connective tissue. Figure 86 .2 (Sacks et al., 1986) diagrams the major features of the human conjunctiva. The conjunctiva has been postulated to possess a system of specific immune defense in the form of mucosa-associated lymphoid tissue (MALT) (Chandler and Gillette, 1983 ). MALT consists of arrangements of lymphatic cells located in and closely beneath the epithelium, which function to detect antigen and induce immune responses by the direct action of the lymphatic cells or by the secretion of soluble antibodies (Kraehenbuhl and Neutra, 1992) . The presence of conjunctiva-associated lymphoid tissue (CALT) has been uncertain. In some animal species, components of MALT were described in conjunctiva, showing species-specific differences (Axelrod and Chandler, 1979; Franklin and Remus, 1984; Latkovic, 1989; Ruskell, 1995; Knop and Knop, 1996; Chodosh et al., 1998a Chodosh et al., , 1998b Chodosh and Kennedy, 2002) . Early human studies using histochemical methods (Kessing, 1968; Allansmith et al., 1978) and more recent immunohistochemical studies analyzing small biopsy specimens (Sacks et al., 1986; Dua et al., 1994; Hingorani et al., 1997) reported differing results as to number and localization of the cells, which did not clearly establish whether conjunctival lymphoid cells formed a functionally active CALT Oral Cavity, Upper Airway, and Head and Neck 1480 ; both IgA1 and IgA2) , IgG, IgM, IgD, and Franklin et al. (1973) ; Allansmith et al. (1976a Allansmith et al. ( , 1985 ; IgE plasma cells Brandtzaeg al. (1979 Brandtzaeg al. ( , 1985 ; Gillette et al. • Suppressor/cytotoxic (predominant), helper, and activated (1980) ; Crago et al. (1984) ; Wieczorek et al. Dua et al. (1994) ; Fujihara et al. (1999) • Surface IgM-(predominant), IgD-, IgG-, or IgA-bearing B cells • HML-1 + (αEβ7) lymphocytes • Macrophages, monocytes, and dendritic cells Rabbit • IgA (predominant) and IgG plasma cells Shimada and Silverstein (1975) ; Franklin et al. (1979) ; Jackson and Mestecky (1981) 

• IgA (predominant), IgG (IgG1, IgG2a, IgG2b, IgG2c) Gudmundsson et al. (1985a) ; Sullivan et al. (1990c) ; and IgM plasma cells Allansmith et al. (1987) ; Hann et al. (1988) ; • Surface IgM-, IgA-, and IgG-bearing B cells Pappo et al. (1988) ; Montgomery et al. (1990) ; • Macrophages, mast cells Williams et al. (1994) ; O' Sullivan et al. (1998 , • Recent thymic emigrants, suppressor/cytotoxic, helper, 2001 ; Sullivan et al. (1998) Knop and Knop (2000) analyzed whole mounts of normal human conjunctival sacs and determined the associated lymphoid tissue contains all the components necessary for an immune response and that expression of IgA and secretory component indicates that conjunctiva belongs to the mucosal immune system. Lymphoid tissue was mainly observed in the palpebral conjunctiva, more pronounced in the upper lid than the lower. Diffuse lymphoid tissue of lymphocytes (predominantly T cells) and plasma cells (most of which were IgA + ) formed a thin layer in the lamina propria of all the conjunctival sacs. The overlying epithelium produced secretory component. In three-fifths of the specimens, organized follicular accumulations having a lenticular shape, composed of B lymphocytes, and covered by a lymphoepithelium were embedded in the diffuse lymphoid layer. High endothelial venules were present in all types of lymphoid tissue (Knop and Knop, 1996 , 2000 . Unlike the M cell containing follicle-associated epithelium (FAE) covering Peyer's patches, no differences between the appearance of microvilli of conjunctival FAE and that of nonfollicle-associated epithelium were noted by transmission electron microscopy in 13 mammalian species (Chodosh et al., 1998b; Chodosh and Kennedy, 2002) . Despite the apparent ubiquity of conjunctival lymphoid follicles in rabbits, ferrets, guinea pigs, cats, dogs, pigs, sheep, cows, rhesus monkeys, baboons, owl monkeys, bush baby monkeys, and humans, few or no lymphoid tissues were identified in mice or rats (Setzer et al., 1987; Chodosh et al., 1998b) , although MALT has recently been demonstrated in nictitating membranes of mice (Sakimoto et al., 2002) . Similar lymphoid tissue was also observed inside the lacrimal drainage system and has been termed lacrimal drainageassociated lymphoid tissue (LDALT) (Knop and Knop, 2001) . The presence of organized CALT appears to be related to antigenic exposure, as evidenced by the rapid increase in conjunctival lymphoid tissue in early youth and a reduced amount under germfree conditions (McMaster et al., 1967) . CALT and LDALT appear to be regularly present and to belong to the common mucosal immune system and to the secretory immune system. Together with the lacrimal gland, they may form a functional unit connected by tear flow, lymphocyte migration, and probably the neural reflex arc, and play a major role in preserving ocular surface integrity (Knop and Knop, 2000; Rolando and Zierhut, 2001; Knop and Knop, 2001) . In addition, the conjunctiva contains the immunologic capacity for antigen processing, cell-mediated immunity, and hypersensitivity responses Chandler and Gillette, 1983; Hann et al., 1985; Sacks et al., 1986; Cornell-Bell et al., 1986; Abelson and Smith, 1991; Montgomery and Whittum-Hudson, 1996) .

Although the conjunctiva and the cornea are similarly exposed to the outside environment, the defensive mechanisms of the two tissues are fundamentally different. Whereas the conjunctiva is a highly reactive tissue that is protected by a potent immune system, the cornea is relatively unreactive, with the immune system repressed to some extent to avoid inflammatory reactions that could compromise the cornea's transparency. Defense is aided by cell polarity, tight cell junctions, and continual replacement of the epithelium. The epithelium produces very high levels of membrane-bound complement inhibitors, PAI-2, and has the ability to produce alpha2-macroglobulin and alpha1-antiproteinase, thereby reducing the risk of autologous cell damage (Sack et al., 2001) . The cornea also produces very high levels of antioxidants (Rose et al., 1998) that may protect the ocular surface from reactive oxygen species produced by activated PMN cells. The cornea possesses interstitial IgA, IgG, IgM, IgD, and IgE, which appear to originate from serum, diffuse from the limbal to central regions, and require extended time periods (e.g., months) for complete turnover (Allansmith and McClellan, 1975; Verhagen et al., 1990; Pleyer et al., 1996) . SC is not produced by the "normal" avascular corneal epithelium or stroma . The peripheral cornea, which is in close contact to the conjunctival vasculature, may also contain Langerhans cells and macrophages (Pleyer et al., 1996) . Although early studies determined that lymphocytes and differentiated Langerhans cells are essentially absent from the normal central cornea (Allansmith et al., 1978; Seto et al., 1987) , recent studies using immunohistochemical confocal microscopic analyses of rodent corneal whole mounts have demonstrated the presence of small numbers of CD3 + T cells (both CD4 + and CD8 + ), macrophages, and dendritic cells (Langerhans cells), but no B cells, in the peripheral cornea and limbus (Yang et al., 1998) . In addition to these peripheral cells, a novel MHC class II-negative population of resident corneal Langerhans-type dendritic cells has been identified in the central cornea (Hamrah et al., 2002) . The corneal stroma is endowed with at least three bone marrow-derived dendritic cell subsets (Hamrah et al., 2003) as well as a novel macrophage population (Brissette-Storkus et al., 2002) . In inflammation these dendritic cells become activated, as evidenced by expression of B7 costimulatory markers, and following corneal transplantation, express MHC class II and migrate to the draining lymph nodes (Liu et al., 2002b; Hamrah et al., 2003) . These findings refute the tenet that the cornea is immune privileged because of lack of resident lymphoreticular cells or because of antigenic sequestration from systemic immunity. Membrane-bound or soluble chemotactic factors, locally produced in the periphery, prevent Langerhans cell migration from the limbus unless a stronger stimulus (e.g., IL-1) is produced. IL-1β is secreted by corneal epithelial cells in response to IFNγ or bacterial infection (Wakefield and Lloyd, 1992) . Further, normal keratocytes express MHC class II molecules in response to inflammation, suggesting that keratocytes collaborate with APC in antigen presentation to T cells, leading to activation of the humoral response, cell-mediated immunity, and inflammation (Niederkorn, 1990) . During inflammation, macrophages and neutrophils extravasate from the vasculature and generate cytokines including TGF-β IL-1, IL-6, and TNF-β that facilitate T-cell and B-cell differentiation and activation. Cytokines produced by immune cells and keratocytes exacerbate the inflammatory response, complement-mediated cytotoxicity, and angiogenesis. To counter the cytotoxic damage that may ensue from inflammation, the cornea protects itself by producing TGF-β which suppresses cell-mediated immune responses, and Fas-L, which prevents cell-mediated damage to the epithelial cells (Sack et al., 2001) .

The preocular tear film plays a critical role in the eye's defense against microbial and antigenic exposure, as well as in the maintenance of corneal clarity and visual ability (Holly, 1987; Lemp and Marquardt, 1992; Lemp, 1995; Rolando and Zierhut, 2001) . These functions are extremely dependent upon the stability, tonicity, and composition of the tear film structure, the actual architecture of which is not totally resolved. Classically, the tear film has been considered to include an underlying mucin foundation, a middle aqueous component, and an overlying lipid layer (Holly, 1987; Whitcher, 1987; Dartt, 1992) . Recently, a two-layered structure with an underlying aqueous-mucin gel, in which the mucins have a decreasing gradient of concentration from the epithelium to the surface, and an overlying lipid layer, has been proposed (Dilly, 1994) . The thickness of the tear film is also under discussion (Rolando and Zierhut, 2001) . There is evidence that the mucous layer of the film could be as thick as 30 μm, but a thinner film has also been hypothesized. Recent evidence suggests a 3 μm thickness for the tear film (King-Smith et al., 2000) . Alteration, deficiency, or loss of the tear film may significantly increase the susceptibility to ocular surface desiccation and infection, corneal ulceration and perforation, and marked visual impairment and blindness (Lamberts, 1983; Whitcher, 1987; Lubniewski and Nelson, 1990; Lemp and Marquardt, 1992; Lemp, 1995) .

The largest part of the mucinous content of the tear film is produced by conjunctival goblet and epithelial cells, and closely adheres to the surface of the globe. The major mucin species is MUC5AC, present in a variety of molecular sizes and glycoforms (Gipson and Inatomi, 1998; Jumblatt et al., 1999) . The corneal and conjunctival epithelial cells produce a mucinlike glycoprotein (MUC1) at the apical surfaces that constitutes a glycocalyx, which binds loosely to the mucin layer (Gipson and Inatomi, 1998) . This transmembrane mucin facilitates tear film spreading and ocular surface wetting and prevents adherence of foreign debris, cells, or pathogens to the ocular surface. The mucins account for the viscoelastic properties of the tear film, maintaining the dioptic integrity in the interblink period, and minimize the trauma to the ocular surface during blinking (Dilly, 1985; Tiffany, 1994) . There is evidence that S-IgA and small, basically charged tear proteins such as lysozyme accumulate in the ocular mucin layer (Chao et al., 1990; Bogart et al., 1994) .

Specific immunity at the ocular surface is mediated primarily through the action of IgA antibodies, which are the predominant immunoglobulin in tears of humans and experimental animals, occur almost entirely in polymeric form, and originate primarily from local production in lacrimal gland plasma cells (Chao et al., 1980; Janssen and van Bijsterveld, 1983; Sullivan and Allansmith, 1984; Peppard and Montgomery, 1987) . In humans, tear IgA is distributed almost equally among IgA1 and IgA2 subclasses (Delacroix et al., 1982) . Most tear IgA appears to be bound to, and transported by, SC, which is synthesized and secreted by lacrimal epithelial cells (Franklin et al., 1973; Gudmundsson et al., 1985; Hann et al., 1989 Hann et al., , 1991 Kelleher et al., 1991; Sullivan et al., 1998) and is present in the tear film as an S-IgA conjugate or as free SC. In addition, although tear Ig levels do not appear to display diurnal rhythms, IgA concentrations may be exceedingly high after prolonged closure of the eyelids (Sack et al., 2000 (Sack et al., , 2001 . S-IgA has significant function in antigen-antibody clearance from the tear film. S-IgA or free SC can agglutinate antigen-IgG complexes (Sack et al., 2002) . Further, PMN cells have an S-IgA receptor and it appears that S-IgA can opsonize bacteria for PMN cell processing (Sibille et al., 1987; Nikolova and Russell, 1995) . S-IgA can also stimulate effector functions in eosinophils (Motegi and Kita, 1998) . Antigen-IgA complexes will not ordinarily activate complement, and, therefore, S-IgA is considered anti-inflammatory in nature (Nikolova et al., 1994) . The role of S-IgA may not be essential in antimicrobial defense because an SC knockout mouse does not exhibit a greater frequency of serious ocular or other mucosal infections . However, lack of J chain inhibits transepithelial transport of IgA and abrogates the development of intestinal antitoxic protection in knockout mice (Lycke et al., 1999) .

Nearly 500 proteins have been identified in normal human tear fluid, including mucins, growth factors, tissue maintenance factors, and antimicrobial agents, the nature of which suggest contributions from serum exudate, lacrimal and accessory gland secretions, ocular surface components, and secreted products of PMN cells (Fung et al., 2002) . The major sources of the tear aqueous layer are lacrimal and accessory gland secretions.These secretions are derived from two independent processes: a slow constitutive ongoing secretion, consisting of almost exclusively secretory IgA and smaller amounts of free SC, and an inducible neurologically controlled lacrimal secretion. Although complex, the inducible lacrimal secretion consists of predominantly three proteins-lysozyme, lactoferrin, and tear-specific lipocalins, each of which exhibits anti-inflammatory and antimicrobial properties (Sack et al., 2001) .

Lactoferrin represents 21% of the total reflex tear protein. The anti-inflammatory and antimicrobial functions of lactoferrin are attributed to its capacity to bind divalent cations and numerous ligands, as well as its basically charged peptide sequence near the N-terminus. Lactoferrin inhibits complement activation, decreases the capacity of PMN cells to release oxygen radical species, and chelates iron, thereby depriving many bacteria of a necessary nutrient. Lactoferrin destabilizes the cell wall of gram-negative bacteria by its chelation actions. The cationic detergent function of the highly basic N-terminal sequence (lactoferricin) disrupts the cell membrane of some gram-negative bacteria (e.g., Pseudomonas, E. coli, Proteus), Staphylococcus aureus, yeast, and filamentous fungi, as well as some viruses including HIV and HCMV (Kijlstra, 1990; Sack et al., 2000 Sack et al., , 2001 .

Lysozyme represents ~33% of the reflex tear proteins. This enzyme cleaves the polysaccharide backbone of the murein layer of the bacterial cell wall as well as chitin in the fungal cell wall. Further, lysozyme can inhibit HIV transmission and inhibits complement activation (McClellan, 1997; Sack et al., 2000 Sack et al., , 2001 .

Tear-specific lipocalins (TSL), which represent ~25% of the reflex tear proteins, contain a putative functional cystatin-like protease inhibitory domain that has been suggested to protect the ocular surfaces from microbe-derived cysteine proteases. Other properties of TSL are consistent with an ocular defense function. Tear proteins, including lactoferrin, lysozyme, and S-IgA, complex with TSL. A lipid-binding domain allows TSL to transport lipids (e.g., retinol) essential for maintenance of goblet and epithelial cell integrity.This domain may also allow the removal or sequestration of toxic lipids such as endotoxin (Glasgow et al., 1999) . Further, TSLs convert hydrophobic surfaces to hydrophilic ones, a property that may be useful in clearing hydrophobic foreign objects from the ocular surface and which affects tear surface tension (Gachon and Lacazette, 1998; Sack et al., 2000 Sack et al., , 2001 .

When the rate of reflex tear secretion decreases, the constitutively secreted S-IgA becomes the fourth major protein constituent. In addition, the open eye tear fluid contains numerous other proteins that have anti-inflammatory and antimicrobial properties, including specific leukocyte protease inhibitor, elafin, and pro-and active members of the α and β defensin families. Other antimicrobial agents detected in the open eye tear fluid include β-lysin, TFF peptides, CAP-37, CAP-38, phospholipase A2, and PMN cell defensins and elastase. Also, antiproteases, various cytokines, vitronectin and neutrophil gelatinase-specific lipocalin have been detected. The reader is referred to Sack et al. (2001) for an excellent review.

Overnight eye closure is associated with an increase in S-IgA, vitronectin, elastase, α1-antitrypsin, specific leukocyte protease inhibitor, fibronectin, and albumin levels; the appearance of complement components C1q, C3, factor B, C4, C5, and C9; the conversion of complement C3 to C3c; plasminogen activation; and the recruitment of PMN cells into the tear film, as well as an enhanced incidence of gram-positive bacteria in the conjunctival sac (Sack et al., 2000 (Sack et al., , 2001 .

The principal role of the outer lipid layer is to prevent evaporation of the tears and enhance the stability of the tear film, thereby indirectly contributing to the antimicrobial nature of the tear film (Sack et al., 2001; Rolando and Zierhut, 2001) . It consists of a variety of lipid constituents, including waxy esters, triglycerides, free fatty acids, and polar lipids secreted by meibomian glands located within the tarsal plates (McCulley and Shine, 2001) .

Other tissues, organisms, and factors involved in nonspecific mucosal defense of the eye include the (1) orbital skeletal structure, which minimizes potential trauma; (2) eyelid architecture, which is relatively impermeable to macromolecules;

(3) eyelid blink reflex and ciliary movement, which rapidly clear foreign objects from the ocular surface; and (4) continuous tear flow and reflex tearing, which act to remove microorganisms and cellular debris through hydrokinetics and eventual drainage into the nasolacrimal duct (Smolin, 1985) . In addition, the presence of resident conjunctival populations of nonpathogenic bacteria, consisting of aerobes and facultative and obligate anaerobes, may curtail the ability of invasive bacteria to attach and colonize. The normal flora depletes the tear fluid of nutrients, reacts with binding sites that might otherwise be available for pathogens, and secretes bacteriocidins that make the environment less hospitable for the growth of potential pathogens (Sack et al., 2001) .

Mucosal immunity constitutes an important first line of defense that protects the surfaces of the aerodigestive and urogenital tracts, as well as the ocular surface. The various mucosal effector sites are linked by migrating lymphocytes, which give rise to IgA antibody-producing cells. The major features of the mucosal immune network, including the relevance of the mucosal system in immune defense, are detailed in a number of publications Childers et al., 1989) , including this volume. The conjunctiva, lacrimal drainage apparatus, and the lacrimal glands fulfill the criteria for inclusion in the common mucosal immune system. As detailed previously, conjunctiva-associated lymphoid tissue (CALT) in humans and many species functions as an antigen-sampling and, along with its draining lymph nodes, an immune inductive tissue. Also, the conjunctiva may serve as a mucosal immune effector site (Franklin and Remus, 1984; Franklin, 1989; Knop, 1996, 2000) . The nasal-associated lymphoid tissue (NALT) also receives antigen after application to the conjunctival sac (Carr et al., 1996; Ridley Lathers et al., 1998) . In contrast, the lacrimal gland functions as a mucosal effector tissue, receiving antigen-stimulated, IgA-committed B cells after antigen stimulation in the intestinal Peyer's patches or other mucosal inductive sites (Franklin et al., 1985) . It contains IgA-secreting plasma cells, which are responsible for the majority of S-IgA released into the tear fluid.

Antigenic challenge to the surface of the eye may result in a marked accumulation of specific S-IgA, IgG, and IgM antibodies in tears; an accelerated and enhanced anamnestic response after secondary exposure; and the generation of immune resistance to, and protection against, antigen reexposure (Mestecky et al., 1978) . In addition, definitive ocular immune responses, as well as accumulation of Ig-containing cells in lacrimal tissue (Jackson and Mestecky, 1981; Allansmith et al., 1987) , may be stimulated by antigenic challenge to other sites, including subconjunctival, intracorneal, intravitreal, intranasal, oral, intrabronchial, gastric, intraduodenal, intravenous, subcutaneous, intradermal, or intramuscular routes. The nature (e.g., antibody isotype), extent, and kinetics of these immune reactions appear to be dependent upon the form (e.g., live versus inactivated microorganisms; strain), concentration, route, duration, and frequency of antigen administration. Potential immune responses may be augmented, intermittent, suppressed, or absent, as reviewed in Montgomery and Whittum-Hudson (1996) . Moreover, the magnitude of induced ocular immunity may be altered by the use of adjuvants (Peppard et al., 1988; Peppard and Montgomery, 1990) , cytokines (Pockley and Montgomery, 1991; Rafferty et al., 1996) , immunostimulatory DNA (Gill and Montgomery, 2002) , and microspheres (Rafferty et al., 1996; Ridley Lathers et al., 1998) and influenced by the concurrent state of systemic immunity (Waldman and Bergmann, 1987) .

The mechanism by which antigenic exposure to the surface of the eye stimulates a local immune (e.g., IgA) response remains to be elucidated. Direct antigen transfer across the conjunctival epithelium or countercurrent passage through the lacrimal duct appears to be severely restricted (Huang et al., 1989; Kahn et al., 1990; Sullivan et al., 1998) . Furthermore, the immunologic architecture of healthy lacrimal tissue appears to limit its capacity to effectively process and present antigen (Wieczorek et al., 1988) . With respect to conjunctival tissue, its role remains unclear. Consequently, it is possible that the ocular secretory immune response to infectious or toxic substances may require antigenic clearance through the nasolacrimal duct and stimulation of intranasal and gut-associated lymphoid tissue. Consistent with this hypothesis are the following observations: (1) topical application of noninvasive antigens to the rat ocular surface appears to result in passage through the nasolacrimal canal into the gastrointestinal tract, and not retrograde transfer to the lacrimal gland or lymphatic drainage into local lymph nodes (Sullivan et al., 1998) . Similarly, herpes simplex virus in human tears has been shown to flow through the lacrimal canaliculi into the nasal cavity (Yoshida and Hondo, 1992) ;

(2) intranasal, oral, or gastric administration of bacteria, viruses, or other antigens may induce the accumulation of specific tear IgA antibodies and the generation of ocular surface protection (Mestecky et al., 1978; Nichols et al., 1978; Montgomery et al., 1983 Montgomery et al., , 1984a Montgomery et al., , 1984b Bergmann et al., 1986; Waldman and Bergmann, 1987; Czerkinsky et al., 1987; Van Zaane et al., 1987; Peppard et al., 1988; Peppard and Montgomery, 1990; Davidson et al., 1993; Carr et al., 1996; Noriega et al., 1996; Montgomery and Rafferty, 1998; Ridley Lathers et al., 1998; Gill and Montgomery, 2002) .

Remote-site stimulation would most likely involve IgA lymphoblast migration from nasal-or gastrointestinal-associated lymphoid tissue, and from cervical or mesenteric lymph nodes, via the thoracic duct lymph, to the lacrimal gland (Montgomery et al., 1983; McGee and Franklin, 1984; Montgomery et al., 1985; O'Sullivan and Montgomery, 1990; Montgomery and Whittum-Hudson, 1996) , followed by local antibody production and transport to the ocular surface. In contrast, the contribution of serum IgA antibodies to ocular surface defense appears to be minimal or nonexistent (Sullivan and Allansmith, 1984; Montgomery et al., 1984b; Bergmann et al., 1986; Peppard and Montgomery, 1987; Czerkinsky et al., 1987) . IgG antibodies from serum, though, may serve a significant role in certain inflammatory disorders of the eye (Gupta and Sarin, 1983; Mackie and Seal, 1984; Wilhelmus et al., 1986) . Overall, ocular immune protection may be conferred by both local and distant antigenic exposure, with lacrimal tissue acting as a recipient of committed IgA-containing cells that elaborate antigen-specific antibodies. However, the development of an optimal strategy to promote secretory immunity in the eye has yet to be established.

Various ocular and systemic diseases, as well as contact lens wear, may significantly influence secretory immune expression in the human eye. Bacterial, viral, and fungal infections of the ocular surface, exposure to allergens, endocrine abnormalities, or graft versus host disorders may significantly increase levels of specific antibodies, total immunoglobulins, complement proteins, and nonspecific immune factors or induce changes in the lymphocytic profile of the conjunctiva. Of interest, if pathologic alterations are evident in only one eye, immune responses may (Shani et al., 1985) or may not (Centifanto et al., 1989) occur in the contralateral, unaffected eye. With regard to contact lenses, these may bind (Gudmundsson et al., 1985) , and also cause modifications in the concentration of immune components in the tear film. The precise immunologic effects may depend upon the composition of lens material, the efficacy of cleaning regimens, and/or the length of wear (Mannucci et al., 1984; Vinding et al., 1987) .

In contrast, such conditions as IgA deficiency, ocular surgery, keratoconjunctivitis sicca, malnutrition, or autoimmune disease may often suppress ocular mucosal immunity. Thus, for example, pigmentary keratitis has been linked to tear S-IgA insufficiency (Fullard et al., 1995) , and severe malnutrition may lead to a significant decrease in tear IgA and SC concentrations, a diminished number of IgAcontaining cells in lacrimal tissue, and a blunted S-IgA antibody response to infectious challenge (Watson et al., 1985; Sullivan et al., 1990b) . Similarly, autoimmune disorders such as multiple sclerosis or Sjögren's syndrome may significantly alter or disrupt immune function in the eye. Multiple sclerosis, an autoimmune disease of possible viral origin, is associated with heightened levels of monomeric IgA and lymphocytes and reduced amounts of SC in tears of afflicted individuals (Coyle, 1989 ). Sjögren's syndrome, an autoimmune disease that occurs almost exclusively in females, is characterized by a progressive lymphocytic infiltration into the lacrimal gland, an immune-mediated destruction of lacrimal acinar and ductal epithelial cells, decreased tear IgA content, and keratoconjunctivitis sicca (Moutsopoulos and Talal, 1987; Kincaid, 1987; Homma et al., 1994; Sullivan, 1994) . Furthermore, in experimental models of this complex disorder, the generation of autoantibodies (Ohashi et al., 1985) and autoreactive T cells to (Tsubata et al., 1996) , and the deposition of IgG, IgA, and complement in ductal epithelial cells of (deLuise et al., 1982) , lacrimal tissue may accompany the striking glandular inflammation (Jabs et al., 1985; Jabs and Prendergast, 1988; Tsubata et al., 1996; Takahashi et al., 1996; Robinson et al., 1998; van Blokland and Versnel, 2002) . The etiology of Sjögren's syndrome may involve the endocrine system (Ansar et al., 1985; Talal and Ahmed, 1985; Nelson and Steinberg, 1987; Ahmed et al., 1989; Homo-Delarche et al., 1991; Homo-Delarche and Durant, 1994; Sullivan, 1994 Sullivan, , 1997 but may also be due to primary infection by, and reactivation of, Epstein-Barr virus (EBV), cytomegalovirus (CMV), herpes virus-6, hepatitis C, or retroviruses (Burns, 1983; Fox, 1988; Green et al., 1989; Krueger et al., 1990; Mariette et al., 1991; Fox et al., 1991; Pflugfelder et al., 1993; Mariette et al., 1993; Pepose et al., 1996) . These viruses have been identified in lacrimal and/or salivary tissues of Sjögren's patients (Burns, 1983; Fox et al., 1986; Fox, 1988; Krueger et al., 1990; Garry et al., 1990; Mariette et al., 1991; Pflugfelder et al., 1993; Tsubota et al., 1995; Pepose et al., 1996) and may possibly stimulate the inappropriate, epithelial cell HLA-DR expression, T helper/inducer cell activation, B-cell hyperactivity, and autoantibody production evident in these affected tissues (Moutsopoulos and Talal, 1987; Maini, 1987; Fox, 1988; Homma et al., 1994) . In support of this possibility, certain viral infections in experimental animals exert a striking impact on the lacrimal gland and induce a periductular infiltration of plasma cells, lymphocytes and macrophages, distinct nonsuppurative periductular inflammation, significant interstitial edema, widespread necrosis of the acinar and ductal epithelium, degenerative and atrophic alterations in epithelial cells, diminished tear flow, and keratoconjunctivitis sicca (Jacoby et al., 1975; Green et al., 1989) . Moreover, recent research has demonstrated that herpes viruses (i.e., cytomegalovirus) and coronaviruses (i.e., sialodacryoadenitis virus) may invade and replicate in rat lacrimal gland acinar cells Wickham et al., 1997) , EBV may bind to specific receptors in ductal epithelium of the human lacrimal gland (Levine et al., 1990) , and human immunodeficiency virus infection may predispose patients to keratoconjunctivitis sicca (Couderc et al., 1987; Ulirsch and Jaffe, 1987; De Clerck et al., 1988; Lucca et al., 1990; Neves et al., 1994) . However, the precise role of viruses in the induction of autoimmune disease, as well as the mechanism by which viral infection may interfere with lacrimal gland function and immune expression, remains to be determined.

For many years it has been recognized that the endocrine and nervous systems regulate multiple aspects of cellular and humoral immunity.This hormonal and neural control, which significantly influences such parameters as lymphocyte differentiation and maturation, antigen presentation, cytokine production, cell migration, and antibody synthesis, is regulated by two major mechanisms: (1) the hormonal stress response and the production of glucocorticoids, and (2) the autonomic nervous system with the release of noradrenalin (Webster et al., 2002) . The central nervous system can also regulate the immune system locally via the release of neuropeptides from peripheral nerves and by locally produced corticotrophin-releasing hormone (Levite, 2000; Elenkov et al., 2000) . Moreover, this neuroendocrine-immune interrelationship is bidirectional, and antigenic exposure may also induce the lymphocytic secretion of cytokines, hormones, and neuropeptides that directly modulate endocrine and neural function (Mulla and Buckingham, 1999; Besedovsky and del Rey, 2000) . In fact, it has been proposed that the immune system serves as a sensory organ, providing input to the endocrine and nervous compartments in response to noncognitive stimuli, such as infection (Blalock, 1984) . Consequently, an extensive, triangular association appears to exist between the endocrine, nervous, and immune systems that acts to promote and maintain homeostasis (Befus et al., 1999; Petrovsky, 2001; Eskandari and Sternberg, 2002; Webster et al., 2002) .

In the mucosal immune system, diverse hormones and neural agonists may significantly modify the (1) accumulation, proliferation, retention and/or function of IgA-and IgG-positive cells, T cells, mast cells, eosinophils, basophils, natural killer cells, polymorphonuclear leukocytes, and/or macrophages; (2) synthesis, appearance, and/or secretion of IgA and IgG antibodies, growth factors, cytokines, adhesion molecules, apoptotic factors, the expression of MHC Class II antigens, the elaboration and release of SC, and the uptake and transport of pIgA into luminal secretions; and (3) adherence and presentation of microorganisms to mucosal cells, the magnitude of neurogenic inflammation, and the extent of local immune protection against infectious agents. In addition, antigen-induced immune responses may significantly alter mucosal neuroendocrine structure, sensitivity, and/or function (Stead et al., 1987; Weisz-Carrington, 1987; Stead et al., 1991; Bienenstock, 1993; Wira and Prabhala, 1993; Wood, 1993; Lambert et al., 1994; Gao et al., 1995; Sullivan and Edwards, 1997; Sullivan, 1997; Sullivan et al., 1998; Befus et al., 1999) .

With regard to the ocular mucosal immune system, endocrine (androgens, but not estrogens or stress hormones) and neural factors appear to exert a dramatic impact on immunologic expression and activity. However, although this neuroendocrine-immune interrelationship has been definitively shown in eyes of experimental animals, it has yet to be evaluated in humans. In rats, androgens elicit a marked increase in the production and secretion of SC by lacrimal gland acinar cells Kelleher et al., 1991; Lambert et al., 1994; Sullivan et al., 1998) , enhance the concentration of IgA in lacrimal tissue (Sullivan et al., 1998) , and stimulate the transfer and accumulation of SC and IgA, but not IgG, in tears (Sullivan and Edwards, 1997; Sullivan et al., 1998) . These hormone actions, which may be induced by various androgenic compounds (Sullivan et al., 1998) , are not duplicated by estrogen, progestin, glucocorticoid, or mineralocorticoid treatment (Sullivan and Edwards, 1997; Sullivan et al. 1998) . Moreover, the immunologic effects of androgens appear to be unique to the eye, because androgen administration does not seem to influence IgA or SC levels in salivary, respiratory, intestinal, uterine, or bladder tissues (Sullivan et al., 1998) and actually suppresses mucosal immunity in the mammary gland (Weisz-Carrington et al., 1978) . The mechanism by which androgens regulate ocular SC dynamics may well involve hormone association with specific nuclear receptors in lacrimal gland acinar cells, binding of these androgen/receptor complexes to genomic acceptor sites, and the promotion of SC mRNA transcription and translation. In support of this hypothesis, saturable, highaffinity and androgen-specific receptors, which adhere to DNA, have been identified in lacrimal tissue (Ota et al., 1985; Sullivan et al., 1998) . In addition, androgens increase SC mRNA levels in lacrimal glands (Gao et al., 1995) . Androgen-induced SC production by acinar cells may be inhibited by androgen receptor (cyproterone acetate), transcription (actinomycin D), or translation (cycloheximide) antagonists (Lambert et al., 1994) . In contrast, the processes underlying androgen action on IgA in the rat eye, as well as this hormone's enhancement of tear IgA levels in the mouse (Sullivan and Edwards, 1997) , remain to be determined.

Androgen activity may also explain the pronounced, sexrelated differences in the rat ocular secretory immune system. Thus, the number of IgA-containing cells, and the IgA and SC output, are significantly greater in adult male lacrimal tissue, as compared with that of adult females. This sexual dimorphism also extends to tears, wherein from puberty to senescence, free SC and IgA, but not IgG, occur in considerably higher levels in male rats Sullivan et al., 1998) . Indeed, androgen influence may well be involved in the distinct sex-associated differences in the structural appearance, histochemistry, biochemistry, immunology, and molecular biologic expression of the lacrimal gland in a variety of species, including mice, hamsters, guinea pigs, rats, rabbits, and humans (Waterhouse, 1963; Cavallero, 1967; Hahn, 1969; Lauria and Porcelli, 1979; Cornell-Bell et al., 1985; Cripps et al., 1986; Sullivan and Allansmith, 1988; Hann et al., 1988; Pangerl et al., 1989; Mircheff et al., 1991; Azzarolo et al., 1993; Gao et al., 1995; Rocha et al., 1997; Sullivan et al., 1998; Marcozzi et al., 2000; Madia et al., 2001; Richards et al., 2002; Liu et al., 2002a) . With respect to humans, sex appears to influence the (1) degree of lymphocyte accumulation in the lacrimal gland (Waterhouse, 1963) ; (2) IgA concentrations in tears of adults (Sen et al., 1978) , but not the elderly (Sand et al., 1986) ; (3) the levels of TGF-α and EGF in tears (van Setten and Schultz, 1994; Barton et al., 1998) ; and (4) frequency of Sjögren's syndrome-related lacrimal gland immunopathology (Moutsopoulos and Talal, 1987; Kincaid, 1987; Fox, 1992; Homma et al., 1994; . Of interest, androgen administration to animal models of Sjögren's syndrome (i.e., MRL/Mp-lpr/lpr and NZB/NZW F1 female mice) dramatically suppresses the inflammation in, and significantly stimulates the functional activity (e.g., IgA output) of, lacrimal tissue (Sullivan and Edwards, 1997; Sullivan et al. , 1998 . This hormone effect appears to be tissue specific and mediated through a hormone interaction with receptors in epithelial cell nuclei causing altered expression and/or activity of cytokines, proto-oncogenes, and apoptotic factors (i.e., TGF-β1, IL-1 β, TNF-α, c-myb, bcl-2, and Bax) in the lacrimal gland Rocha et al., 1997) .

In addition to androgens, the hypothalamic-pituitary axis appears to play an important role in the expression of the rat ocular secretory immune system. Disruption of this axis by hypophysectomy or extirpation of the anterior pituitary significantly reduces the number of IgA plasma cells in lacrimal tissue, diminishes the acinar cell production of SC, causes a striking decrease in the levels of tear IgA and SC, and almost completely curtails androgen action on ocular mucosal immunity (Gao et al., 1995; Sullivan et al. 1998) . Moreover, this endocrine disturbance has a marked effect on lacrimal gland structure and function, leading to glandular atrophy, acinar cell contraction, nuclear pycnosis, cytoplasmic vacuolar metamorphosis, a decrease in tissue protein and mRNA content, and a decline in fluid and protein secretion (Azzarolo et al., 1992; Sullivan et al. 1998 ). The physiologic mechanisms responsible for hypothalamic-pituitary involvement in the ocular secretory immune system remain to be elucidated, but may include numerous neuroendocrine and immunologic pathways: the hypothalamus and pituitary regulate multiple endocrine circuits, directly influence neural innervation in the lacrimal gland, and clearly modulate immune activity (Berczi, 1990; Berczi and Nagy, 1990) . Furthermore, the hypothalamic-pituitary axis is known to control many hormones, neurotransmitters, and cytokines that modify androgen and acinar cell function and control mucosal immunity (Mooradian et al., 1987; Sullivan et al. 1998) . Other studies in humans or experimental animals demonstrated that (1) sex steroids may significantly alter the development of allergic conjunctivitis in rabbits (Saruya, 1968) ; (2) diabetes may enhance the incidence of keratoconjunctivitis sicca (Ramos-Remus et al., 1994) and significantly diminish the expression of the secretory immune system of the eye, most likely related to the absence of insulin (Jackson and Hutson, 1984; Hann et al., 1991; Sullivan et al. 1998); and (3) both the thyroid and adrenal glands are essential to achieve the full magnitude of androgen-induced effects on the secretory immune system of the eye (Sullivan et al. 1998) .

With respect to neural regulation of ocular mucosal immunity, the stromal, periductal, perivascular, and/or acinar areas of lacrimal tissue are innervated by many parasympathetic, sympathetic, and peptidergic fibers that harbor numerous immunoactive transmitters, including vasoactive intestinal peptide (VIP), substance P, neuropeptide pituitary adenylate cyclase-activating peptide, methionine enkephalin, leucine enkephalin, calcitonin gene-related peptide, neuropeptide Y, dopamine, 5-hydroxytryptamine, and adrenergic and cholinergic agents (Ruskell, 1971; Nikkinen et al., 1984; Walcott, 1990; Dartt, 1992; Williams et al., 1994; Seifert et al., 1996) . These neural agonists are known to control lymphocyte retention and/or function in other mucosal sites (Ottaway, 1984; Walcott et al., 1986; Stanisz et al., 1986; Freier et al., 1987; Hart et al., 1990; D'Orisio and Panerai, 1990; Bienenstock, 1993; Homo-Delarche and Durant, 1994; Chrousos, 1995; Wilder, 1995; Besedovsky and del Rey, 1996) , and their release may well influence the adherence, distribution, or activity of IgA plasma cells, T cells, or mast cells in the lacrimal gland (Franklin et al., 1988; Oeschger et al., 1989; Franklin et al., 1989; Williams et al., 1994) . Consistent with this possibility, VIP appears to augment T-cell attachment to murine lacrimal tissue (Oeschger et al., 1989) , and systemic administration of the β-adrenergic blocker, practolol, suppresses human tear IgA levels (Garner and Rahi, 1976) . However, the nature of the sympatheticimmune interaction requires further clarification because ocular application of the β-blocker, timolol, to humans, and sympathetic denervation in rats (Sullivan et al., 1990a) had no apparent effect on tear IgA content.

More recently, it has been demonstrated that VIP and the β-adrenergic agent, isoproterenol, increase basal-and androgen-stimulated SC production by rat acinar epithelial cells Lambert et al., 1994) . This neural regulation of SC synthesis may be mediated through the modulation of intracellular adenylate cyclase and cAMP activity. In support of this hypothesis, VIP and adrenergic agents are known to enhance the generation of cellular cyclic AMP (Mauduit et al., 1984; Dartt, 1989 Dartt, , 1992 . Furthermore, exposure of lacrimal gland acinar cells to cyclic AMP analogues, cyclic AMP inducers (i.e., PGE 2 and cholera toxin), or phosphodiesterase inhibitors may elevate SC production . This cAMP influence on SC elaboration, although pronounced in the lacrimal gland, is not necessarily reproduced in other mucosal epithelial cells (Lambert et al., 1994) . Of interest, cAMP and cGMP both appear to increase S-IgA output by human main and accessory lacrimal glands in vitro (Hunt et al., 1996) . The mechanism underlying this cGMP action, though, is unclear, given that this compound has no effect on SC production by rat lacrimal gland acinar cells .

Cholinergic agonists also modulate the ocular secretory immune system. In humans, parasympathetic agents stimulate the secretion of EGF and TGF-β1 from the lacrimal gland (Yoshino et al., 1996a, b) , whereas in birds, carbachol, by apparently binding to muscarinic acetylcholine receptors on IgG plasma cells, increases IgG output from the Harderian gland (Brink et al., 1994; Cameron et al., 1995) . In contrast, carbamyl choline acutely (i.e., hours) enhances, but chronically (i.e., days) decreases, basal-, cholera toxin-, and androgen-induced SC production by rat lacrimal gland acinar epithelial cells Lambert et al., 1994) . The transient effect of this compound may be mediated through the mobilization of intracellular calcium, the activation of protein kinase C, and the rapid enhancement of cellular secretion (Dartt, 1989; Lambert et al., 1994) . The processes underlying the long-term inhibitory action of carbachol, which may be prevented by atropine, is unknown, but may involve the suppression of cAMP (Jumblatt et al., 1990) or an alteration of gene activity (Lambert et al., 1994) .

Neural pathways also are of importance in the spread of herpes virus infection in the eye (Shimeld et al., 1987) , and ocular viral transmission and activity may be modulated by neuropeptides (Herbort et al., 1989) . Moreover, although the optic nerve does not appear to regulate the ocular secretory immune system (Sullivan et al., 1990a) , light does seem to control anterior chamber-associated immune deviation , herpes virus-related retinitis , and various parameters of systemic immunity (Maestroni et al., 1987) . The mucosal immune system of the eye in experimental animals may also be regulated by cytokines. For example, IL-1α, IL-1 β, and TNF-α, but not IL-6 or IFNγ, stimulate the acinar cell synthesis and secretion of SC . The regulatory effect of TNF-α on acinar cell SC is similar to that found in colonic cell lines, wherein TNF-α, IFNγ, and IL-1 increase the production, surface expression, and release of SC (Kvale et al., 1988) . However, the absence of IFNγ activity on SC output by acinar cells is notable, in that this cytokine regulates SC dynamics in both intestinal (Sollid et al., 1987; Kvale et al., 1988; Nilsen et al., 1999; Blanch et al., 1999) and uterine (Wira and Prabhala, 1993) epithelial cells and may influence lacrimal gland acinar cell secretion (Lambert, 1998) . Although IL-6 appears to have no influence on lacrimal SC production , both IL-6 and IL-5 stimulate the synthesis of IgA in lacrimal tissue explants (Pockley and Montgomery, 1990b) and in combination augment the secondary tear IgA antibody response to pneumococcal antigen (Pockley and Montgomery, 1991) and suppress IgG and IgM synthesis in lacrimal tissue (Pockley and Montgomery, 1990a) . Similarly, TGF-β enhances IgA output from rat lacrimal tissue, whether alone or in combination with IL-2, IL-5, IL-6, or IL-5 plus IL-6 (Rafferty and . However, TGF-β or IL-4 also inhibit lymphocyte binding to lacrimal gland acinar epithelium (Elfaki et al., 1994) .

As a further consideration, androgens, VIP, and IL-1 all share the capacity to increase IgA production in specific tissues (Drew and Shearman, 1985; Stanisz et al., 1986; Sullivan et al. 1998) , and pIgA, in turn, may heighten the monocytic output of TNF-α (Deviere et al., 1991) . If analogous activity occurs in the lacrimal gland, then various neuroimmunoendocrine factors may control the synthesis of both IgA antibodies and the IgA receptor, leading to enhanced antibody transfer to tears and improved ocular surface defense.

In ocular mucosal immunity, the lacrimal gland is the principal effector site where secretory IgA antibodies are produced. These antibodies are transported, via the tears, to the ocular surface where they contribute to protection against allergic, inflammatory, or infectious disease and thus promote corneal and conjunctival health. NALT (the rodent equivalent of human Waldeyer's ring tissue) and its draining posterior cervical lymph node (pCLN) acquire antigen and appear to function as a major inductive site for eliciting tear IgA responses following antigenic challenge to the external ocular compartments. It is thought that nonpenetrating antigen drains from the ocular surface via the nasolacrimal duct and is taken up by the M cells overlaying NALT. Alternately, antigen taken up by the conjunctiva is transported directly to the superficial (s) CLN, thus following an alternate inductive pathway that bypasses the NALT and pCLN (summarized in Fig. 86.3) .

It is now clear that the ocular surface and the LG function as a tightly integrated unit, linked by interconnecting innervation (Stern et al., 1998a, b) . The surface of the eye is heavily innervated, having more afferent nerves than the combined total in the rest of the body. Also, as diagrammed in Figure 86 .3, conjunctival or corneal stimuli are sensed by afferent sensory neurons and the information relayed to the midbrain (lacrimatory nucleus), which also receives neural Fig. 86.3 . Schematic summarizing the ocular mucosal immune system and control of lacrimal gland function. Exogenous (microbe-derived) or endogenous (tissue-derived) stimulatory signals from antigen-challenged mucosal surfaces may be directed to sampling/inductive (conjunctiva, lacrimal drainage-associated lymphoid tissue, nasal-associated lymphoid tissue, cervical lymph nodes) and effector (lacrimal gland) sites resulting in the induction of protective mucosal immune responses. Mucosal surfaces are heavily innervated with afferent nerves leading to the midbrain (lacrimatory nucleus). Cortical input (including input from the gonadal axis) also is received in the midbrain nucleus, a net signal is integrated and then sent through efferent nerves to the lacrimal glands. Cholinergic nerves, using acetylcholine (ACh) and vasoactive intestinal peptide as neurotransmitters, innervate the glands, whereas adrenergic fibers using norepinephrine go to blood vessels (not shown). The lacrimal glands contain M1 and M3 muscarinic acetylcholine receptors (mAChR) and produce secretions (tears) containing water and proteins (including S-IgA and SC) upon efferent stimulation. Sex hormones as well as various neurotransmitters and neuropeptides, via receptors on immunocytes, also influence the outcome of immune responses in the lacrimal gland.

input from higher cortical regions. The net signal is "integrated" and efferent signals are sent to the blood vessels via adrenergic fibers (i.e., norepinephrine as a neurotransmitter) to release water to serve as the volume for tears. A separate set of cholinergic fibers (acetylcholine and VIP as neurotransmitters) is sent to the lacrimal glands and signal acinar and ductal cells (via M3 mAChR) to pump aqueous secretion as tears (Fox and Stern, 2002) . The normal lacrimal gland physiology is influenced by the sex hormone milieu (regulated by the hypothalamic-pituitary-gonadal axis).

Ocular infections can influence efferent neural signaling in the lacrimal gland through induction of cholinergic enzymes, which reduce expression of acetylcholine and modulate receptors (mAChR) on acinar cells and on plasma cells, thereby decreasing fluid and immunoglobulin secretion . Responses involving T lymphocytedependent antigens have been shown to result in production of IL-4 in lacrimal glands as well as influence cholinergic enzyme activity (Sinha et al., 2001) , affecting both immune processes and lacrimal physiology. Further, neuropeptides released into lymphoid structures or inflamed tissues are known to be chemotactic for antigen presenting cells and to affect their interactions with T cells (Lambrecht, 2001) .

Thus, it appears that consideration of the entire ocular compartment, including its connecting innervation, will be important in developing therapeutic approaches for treating dry eye conditions and vaccination strategies for eliciting protective ocular mucosal immune responses.

Mediators of ocular inflammation

Estrogen induces the development of autoantibodies and promotes salivary gland lymphoid infiltrates in normal mice

Ocular anaphylaxis: Induction by local injection of antigen

Secretory component in human ocular tissues

Number of inflammatory cells in the normal conjunctiva

The immune response of the lacrimal gland to antigenic exposure

Tissue, tear, and serum IgE concentrations in vernal conjunctivitis

Plasma cell content of main and accessory lacrimal glands and conjunctiva

Immunoglobulins in the human cornea

Molecular forms of tear IgA and distribution of IgA subclasses in human lacrimal glands

Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action

Bacteriocidal activity of human lactoferrin: Differentiation from the stasis of iron deprivation

Morphologic characteristics of conjunctival lymphoid tissue in the rabbit

Dihydrotestosterone and prolactin reverse lacrimal gland regression after hypophysectomy of female

Sex-dependent parameters related to electrolyte, water and glycoprotein secretion in rabbit lacrimal glands

Cytokines and tear function in ocular surface disease

Integration of neuroendocrine immune responses in defense of mucosal surfaces

Neurohormonal-immune interaction

Effects of hypophysectomy on immune function

Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine

Immune-neuro-endocrine interactions: Facts and hypotheses

The cytokine-HPA axis feedback circuit

Neuroimmune interactions in the regulation of mucosal immunity

The immune system as a sensory organ

Cutting edge: Coordinate regulation of IFN regulatory factor-1 and the polymeric Ig receptor by proinflammatory cytokines

sIgA, glycoproteins and soluble mucin in reflex and closed eye tears. Does the epithelium shed its membrane-bound mucin?

Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man

The human secretory immune system shows striking heterogeneity with regard to involvement of J chain-positive IgD immunocytes

Subclass distribution of IgG-and IgA-producing cells in secretory tissues and alterations related to gut diseases

Cholinergic modulation of immunoglobulin secretion from avian plasma cells: The role of calcium

Identification of a novel macrophage population in the normal mouse corneal stroma

Persistent cytomegalovirus infection-the etiology of Sjögren's syndrome

Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application

Cholinergic modulation of immunoglobulin secretion from avian plasma cells: The role of cyclic mononucleotides

Nasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responses

Relative effectiveness of various steroids in an androgen assay using the exorbital lacrimal gland of the castrated rat

Herpes simplex virus-specific antibodies present in tears during herpes keratitis

Immunologic defense mechanisms of the ocular surface

Characterization of ocular mucus extracts by crossed immunoelectrophoretic techniques

Biosynthesis and partial characterization of tear film glycoproteins. Incorporation of radioactive precursors by human lacrimal gland explants in vitro

Molecular mechanisms of immunoglobulin A defense

The conjunctival lymphoid follicle in mucosal immunology

Anatomy of mammalian conjunctival lymphoepithelium

Comparative anatomy of mammalian conjunctival lymphoid tissue: A putative mucosal immune site

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

Characterization of a localized basophil hypersensitivity lesion in guinea pig conjunctiva

Gender-related differences in the morphology of the lacrimal gland

Sicca complex and infection with human immunodeficiency virus

Molecular analysis of IgA in multiple sclerosis

Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues

Genderdependent lacrimal protein secretion

Oral immunization with bacterial antigen induces IgA-secreting cells in peripheral blood in humans

Neuropeptides and immunopeptides: Messengers in a neuroimmune axis

Pseudomonas aeruginosa corneal infection affects cholinergic enzymes in rat lacrimal gland

Signal transduction and control of lacrimal gland protein secretion: A review

Physiology of tear production

Wetting of the ocular surface

The effect of immunization route on rat serum and tear antibody responses to Chlamydia trachomatis

Acquired immunodeficiency syndrome mimicking Sjögren's syndrome and systemic lupus erythematosus

IgA subclasses in various secretions and in serum

The effects of age, sex, and pregnancy on the histopathology and immunopathology of lacrimal glands of NZB/NZW F1 hybrid mice

IgA triggers tumor necrosis factor alpha secretion by monocytes: A study in normal subjects and patients with alcoholic cirrhosis

Contribution of the epithelium to the stability of the tear film

Structure and function of the tear film

Vaso-active intestinal peptide: A neurotransmitter which reduces human NK cell activity and increases Ig synthesis

Mucosa specific lymphocytes in the human conjunctiva, corneoscleral limbus and lacrimal gland

Secretory immune responses in aging rats. II. Phenotypic distribution of lymphocytes in secretory and lymphoid tissues

The sympathetic nerve-an integrative interface between two supersystems: The brain and the immune system

Inhibition of lymphocyte adherence to rat lacrimal acinar epithelium by interleukin-4 and transforming growth factor-beta 1

Neural-immune interactions in health and disease

Regulation of the systemic immune response by visible light and the eye

Identification of a nonlysozymal bactericidal factor (beta lysin) in human tears and aqueous humor

Epstein-Barr virus and human autoimmune diseases: Possibilities and pitfalls

Reactivation of Epstein-Barr virus in Sjögren's syndrome

Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome

Sjögren's syndrome: Mechanisms of pathogenesis involve interaction of immune and neurosecretory systems

The ocular secretory immune system-A review

Immunohistologic studies of human lacrimal gland: Localization of immunoglobulins, secretory component and lactoferrin

The role of substance P on neuro-immune mechanisms in the lacrimal gland

Neuroregulation of lacrimal gland function

Lacrimal gland-directed B cell responses

Secretory immune system of rabbit ocular adnexa

Conjunctival-associated lymphoid tissue: Evidence for a role in the secretory immune system

T-cell adherence to lacrimal gland: The event responsible for IgA plasma cell predominance in lacrimal gland

Effect of cholecystokinin and of its antagonist, of atropine, and of food on the release of immunoglobulin A and immunoglobulin G specific antibodies in the rat intestine

Preferential localization of CD8 + αEβ7 T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome

Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS

Mass spectrometric techniques applied to the analysis of human tears: A focus on the peptide and protein constituents

Tear lipocalin and the eye's front line of defence

Androgen control of secretory component mRNA levels in the rat lacrimal gland

Practolol and ocular toxicity

Detection of a human intracisternal A-type retroviral particle antigenically related to HIV

Enhancement of rat tear IgA antibody responses following intranasal immunization with antigen and CpG ODN

Lactoferrin in human ocular tissues

Histologic and immunohistologic comparison of main and accessory lacrimal tissue

Immunohistochemical localization of human tear lysozyme

Cellular origin of mucins of the ocular surface tear film

Tear lipocalins: Potential lipid scavengers for the corneal surface

Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice

The ocular secretory immune system of the rat

Serum and tear immunoglobulin levels in acute adenovirus conjunctivitis

Effect of cyproterone acetate on sexual dimorphism of the exorbital lacrimal gland in rats

The corneal stroma is endowed with a significant number of resident dendritic cells

Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells

Impact of aging and gender on the Ig-containing cell profile of the lacrimal gland

Conjunctival basophil hypersensitivity lesions in guinea pigs. Analysis of upper tarsal epithelium

Influence of culture conditions on the androgen control of secretory component production by acinar cells from the rat lacrimal gland

Morphology and function of lacrimal gland acinar cells in primary culture

Effect of substance P on immunoglobulin and interferon-gamma secretion by cultured human duodenal mucosa

Contralateral HSV-1 retinitis is dependent upon visible light

Innate defence of the eye by antimicrobial defensin peptides

Role of peptidergic neurons in ocular herpes simplex infection in mice

Characterization of the normal conjunctival leukocyte population

Tear film physiology

Sjögren's Syndrome: State of the Art

Hormones, neurotransmitters and neuropeptides as modulators of lymphocyte functions

Sex steroids, glucocorticoids, stress and autoimmunity

Paracellular permeability of corneal and conjunctival epithelia

Analysis of cytomegalovirus infection and replication in acinar epithelial cells of the rat lacrimal gland

Organ culture of human main and accessory lacrimal glands and their secretory behaviour

Ocular inflammation in autoimmune MRL/Mp mice

Murine models of Sjögren's syndrome. Immunohistologic analysis of different strains

Altered responses to androgen in diabetic male rats

Oral-parenteral immunization leads to the appearance of IgG auto-anti-idiotypic cells in mucosal tissues

Pathogenesis of sialodacryoadenitis in gnotobiotic rats

Nonlysozyme antibacterial factor in human tears. Fact or fiction?

Origin and biosynthesis of human tear fluid proteins

Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice

MUC5AC mucin is a component of the human precorneal tear film

Muscarinic cholinergic inhibition of adenylate cyclase in the rabbit iris-ciliary body and ciliary epithelium

Penetrating the conjunctival barrier. The role of molecular weight

Endocrine, neural, and immune control of secretory component output by lacrimal gland acinar cells

Mucous gland system of the conjunctiva. A quantitative normal anatomical study

Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues

Inhibition of C3 deposition on solidphase bound immune complexes by lactoferrin

The role of lactoferrin in the nonspecific immune response on the ocular surface

Lactoferrin levels in normal human tears

The eye in Sjögren's syndrome

The thickness of the human precorneal tear film: Evidence from reflection spectra

MALT tissue of the conjunctiva and nasolacrimal system in the rabbit and human

Lacrimal drainage-associated lymphoid tissue (LDALT): A part of the human mucosal immune system

Conjunctiva-associated lymphoid tissue in the human eye

Molecular and cellular basis of immune protection of mucosal surfaces

Latent herpesvirus-6 in salivary and bronchial glands

Regulation of the immune response within privileged sites

Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alpha and gamma interferon

Do cytokines have a role in the regulation of lacrimal gland acinar cell ion transport and protein secretion?

Neuroendocrinimmune modulation of secretory component production by rat lacrimal, salivary, and intestinal epithelial cells

Keratoconjunctivitis sicca

Immunologists getting nervous: Neuropeptides, dendritic cells and T cell activation

Ultrastructure of M cells in the conjunctival epithelium of the guinea pig

Leucine aminopeptidase (LAP) activity and sexual dimorphism in rat exorbital lacrimal gland

Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes

The Dry Eye: A Comprehensive Guide Berlin

Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia

Nerve-driven immunity. The direct effects of neurotransmitters on T-cell function

Identification of androgen-regulated genes in the lacrimal gland

Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts

Diagnosis and management of dry eye and ocular surface disorders

Keratoconjunctivitis sicca in male patients infected with human immunodeficiency virus type 1

Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection

Diagnostic implications of tear protein profiles

Variations of lacrimal fluid peroxidase activity in female and male rats

The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin

The relationship of Sjögren's syndrome to rheumatoid arthritis

The effect of extended wear contact lenses on tear immunoglobulins

Lacrimal fluid peroxidase activity during the menstrual cycle

Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome

Hepatitis C virus and Sjögren's syndrome

Protein secretion induced by isoproterenol or pentoxifylline in lacrimal gland: Ca2+ effects

Mucosal defense of the outer eye

The lipid layer: The outer surface of the ocular surface tear film

Lymphocyte migration into the lacrimal gland is random

Mechanisms of the host response in the eye, IV: The anterior eye in germ-free animals

Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response

Selective induction of an immune response in human external secretions by ingestion of bacterial antigen

Class II antigen expression by lacrimal epithelial cells. An updated working hypothesis for antigen presentation by epithelial cells

Induction of secretory and serum antibody responses following oral administration of antigen with bioadhesive degradable starch microparticles

Induction and expression of antibodies in secretions

The effect of immunization route and sequence of stimulation on the induction of IgA antibodies in tears

Regulation of lacrimal gland immune responses

A comparison of lymphocyte subset distribution in rat lacrimal glands with cells from tissues of mucosal and non-mucosal origin

Parameters influencing the expression of IgA antibodies in tears

Evidence for migrating of IgA bearing lymphocytes between peripheral mucosal sites

Mucosal immunity in the ocular system

Biological actions of androgens

Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils

Immunologic abnormalities in Sjögren's syndrome

Regulation of the hypothalamo-pituitary-adrenal axis by cytokines

Sex steroids, autoimmunity, and autoimmune diseases

Lacrimal dysfunction in pediatric acquired immunodeficiency syndrome

Use of enteric vaccines in protection against chlamydial infections of the genital tract and the eye of guinea pigs

Immune privilege and immune regulation in the eye

The lacrimal glands of the rat and the guinea pig are innervated by nerve fibers containing immunoreactivities for substance P and vasoactive intestinal polypeptide

Dual function of human IgA antibodies: Inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells

All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone

Different regulatory pathways employed in cytokineenhanced expression of secretory component and epithelial HLA class I genes

Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli

Selective interactions of lymphocytes with neonatal and adult lacrimal gland tissues

Lymphocyte adhesive interaction with lacrimal gland acinar epithelium involves carbohydrate recognition

Lymphocyte adhesive interactions with lacrimal gland acinar epithelial cells in primary culture

In vitro adhesive interactions between rat lymphocytes and lacrimal gland acinar epithelium. Phenotype of adherent lymphocytes and involvement of adhesion molecules

Rat lacrimal glands contain activated and resting mature T cells, recent thymic emigrants, and possibly extrathymic populations

Development of T cell lineages in rat lacrimal glands

Regulation of T-cell migration: Effect of neuropeptides and cell factors on the binding of T-cells to lacrimal gland epithelial cells

The presence of cytotoxic autoantibody to lacrimal gland cells in NZB/W mice

Demonstration and characterization of cytosol androgen receptor in rat exorbital lacrimal gland

In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells

Betaadrenoceptors in the extraorbital lacrimal gland of the Syrian hamster. Characterization with [125I]-iodopindolol and evidence of sexual dimorphism

Phenotype of mononuclear leukocytes resident in rat major salivary and lacrimal glands

91996) Ocular Infection and Immunity

Antibody production in rats following ocular-topical or gastrointestinal immunization: Kinetics of local and systemic antibody production

Studies on the origin and composition of IgA in rat tears

Optimizing the expression of antibodies in tears: Manipulation of the common mucosal immune system?

Towards a unified model of neuroendocrineimmune interaction

Epstein-Barr virus and the lacrimal gland pathology of Sjögren's syndrome

Identification of lacrimal gland associated immunomodulatory activities having differential effects on T and B cell proliferative responses

The effects of interleukins 5 and 6 on immunoglobulin production in rat lacrimal glands

In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses

Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system

Effects of transforming growth factor beta on immunoglobulin production in cultured rat lacrimal gland tissue fragments

Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome

Gender-related differences in gene expression of the lacrimal gland

Inductive pathways leading to rat tear IgA antibody responses

Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune nod mice

Influence of gender, androgens and cyclophosphamide on cytokine mRNA levels in lacrimal tissue of a mouse model of Sjögren's syndrome

The ocular surface and tear film and their dysfunction in dry eye disease

Ocular oxidants and antioxidant protection

The distribution of autonomic post-ganglionic nerve fibres to the lacrimal gland in monkeys

Organization and cytology of lymphoid tissue in the cynomolgus monkey conjunctiva

Towards a closed eye model of the pre-ocular tear layer

Host-defense mechanism of the ocular surfaces

Lymphocytic subpopulations in the normal human conjunctiva. A monoclonal antibody study

Unique characteristics of lacrimal glands as a part of the mucosal immune network: High frequency of IgA-committed B-1 cells and NK1.1 + αβ T cells

Histological study of conjunctiva-associated lymphoid tissue in mouse

Changes in the concentration of secretory immunoglobulin A in tears during post-operative inflammation of the eye

Differential distribution of neuronal markers and neuropeptides in the human lacrimal gland

Biological variation of immunoglobulin concentrations in normal human tears related to age and sex

HLA-DR+/T6-Langerhans cells of the human cornea

Unusual structure of rat conjunctival epithelium. Light and electron microscopy

Studies on HSV specific IgA antibodies in lacrimal fluid from patients with herpes keratitis by solid phase radioimmunoassay

Local antibody formation within the eye: A study of immunoglobulin class and antibody specificity

Spread of HSV-1 to the mouse eye after inoculation in the skin of the snout requires an intact nerve supply to the inoculation site

In vitro effects of IgA on human polymorphonuclear leukocytes

Effects of T-lymphocyte-dependent and -independent immunity on cholinergic enzyme activity in mouse lacrimal glands

The defence mechanism of the outer eye

Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins

Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen

Neuropeptide regulation of mucosal immunity

Interaction of the mucosal immune and peripheral nervous systems

A unified theory of the role of the ocular surface in dry eye

The pathology of dry eye: The interaction between the ocular surface and lacrimal glands

The eye's view of antigen presentation

Possible mechanisms involved in the reduced tear secretion in Sjögren's syndrome

Sex hormones and Sjögren's syndrome

Ocular mucosal immunity

Source of IgA in tears of rats

The effect of aging on the secretory immune system of the eye

Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome

Neural-immune interrelationship: Effect of optic, sympathetic, temporofacial, or sensory denervation on the secretory immune system of the lacrimal gland

Severe protein malnutrition: Impact on tear IgA levels during development and aging

Aqueous tear deficiency. In Sjögren's Syndrome: Possible Causes and Potential Treatment

Influence of gender, sex steroid hormones, and the hypothalamic-pituitary axis on the structure and function of the lacrimal gland

Androgens and dry eye in Sjögren's syndrome

Influence of ocular surface antigen on the postnatal accumulation of immunoglobulin-containing cells in the rat lacrimal gland

Mechanism of the development of autoimmune dacryoadenitis in the mouse model for primary Sjögren's syndrome

Sex hormones and autoimmune disease: A short review

Composition and biophysical properties of the tear film: Knowledge and uncertainty

Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome

Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: A spontaneous model for Sjögren's syndrome

Increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjögren's syndrome patients

Sjögren's syndrome-like illness associated with the acquired immunodeficiency syndromerelated complex

Immunoglobulin A: Strategic defense initiative at the mucosal surface

Pathogenesis of Sjögren's syndrome: Characteristics of different mouse models for autoimmune exocrinopathy

Transforming growth factoralpha is a constant component of human tear fluid

Mucosal antibody response of calves after oral and intrabronchial administration of rotavirus

Diffusion of immunoglobulin G from the vascular compartment into the normal rabbit cornea

The concentration of lysozyme and secretory IgA in tears from healthy persons with and without contact lens use

The role of cytokines in the pathogenesis of inflammatory eye disease

Leu enkephalin-like immunoreactivity and the innervation of the rat exorbital gland

Protein and immunoglobulin release from lacrimal gland fragments

Stimulation of secretory antibody following oral antigen administration

Focal adenitis in salivary and lacrimal glands

Effect of age, malnutrition and renutrition on free secretory component and IgA in secretions

Neuroendocrine regulation of immunity

Secretory immunology in the mammary gland

Hormonal induction of the secretory immune system in the mammary gland

Clinical diagnosis of the dry eye

Effect of sialodacryoadenitis virus exposure on acinar epithelial cells from the rat lacrimal gland

Measurement of cytokines in the lacrimal gland and tears: Analysis of various methods

The immunoarchitecture of the normal human lacrimal gland. Relevancy for understanding pathologic conditions

Neuroendocrine-immune system interactions and autoimmunity

Sequential antibody changes following ulcerative herpetic keratitis

Innervation and mast cells of the rat exorbital lacrimal gland: The effects of age

Williams Textbook of Endocrinology

Sex hormone, glucocorticoid, and cytokine regulation of mucosal immunity: Hormonal influences on antibody levels and antigen presentation in the female genital tract

Enteric neuroimmune interactions

Transmission of herpes simplex virus infection via lacrimal canaliculi

Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland

Cholinergic stimulation of lactoferrin and epidermal growth factor secretion by the human lacrimal gland